Download PDF
Journal of Pediatric Epilepsy 2017; 06(03): 156-160
DOI: 10.1055/s-0037-1603493
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Epileptic Seizures Associated with Chromosomal Abnormalities Detected by Array Comparative Genomic Hybridization in Five Albanian Children

Anila Babameto-Laku
1   Service of Medical Genetics, University Hospital Centre “Mother Theresa,” University of Medicine, Tirana, Albania
,
Serla Grabova
2   Service of Neurology, University Hospital Centre “Mother Theresa,” University of Medicine, Tirana, Albania
,
Gentian Vyshka
2   Service of Neurology, University Hospital Centre “Mother Theresa,” University of Medicine, Tirana, Albania
,
Jera Kruja
2   Service of Neurology, University Hospital Centre “Mother Theresa,” University of Medicine, Tirana, Albania
› Author Affiliations
Further Information

Publication History

01 February 2017

18 April 2017

Publication Date:
22 May 2017 (online)

    Permissions and Reprints

Abstract

Epilepsy is an ever-changing field of research, with genetics and genomics playing a very important role in recent times. Novel technologies detecting chromosomal aberrations are applied widely, and array-based comparative genomic hybridization (array CGH) has become a basic diagnostic tool in a variety of neurologic and neuropsychiatric conditions. The authors describe five Albanian children suffering from epilepsy and screened for genetic problems using array CGH and other methods. A thorough neurological examination and imaging studies were performed for all patients, who in addition to seizures, suffered from diverse medical conditions such as microcephaly, developmental delay, intellectual disability, dysmorphic features, heart anomalies, cryptorchidism, and other clinical stigmata of an aberrant neurodevelopment. It is evident from our case reports that the array CGH as a diagnostic tool in molecular genetics has facilitated the recognition of microdeletions and microduplications as risk factors for both generalized and focal epilepsies. This method, therefore, clearly has a practical and scientific value in the investigation of children with epilepsy and associated intellectual disability and congenital anomalies.

Keywords

epilepsy - seizures - chromosomal abnormalities - karyotype - array-based comparative genomic hybridization
 

  • References

  • 1 Garofalo S, Cornacchione M, Di Costanzo A. From genetics to genomics of epilepsy. Neurol Res Int 2012; 2012: 876234 . Doi: 10.1155/2012/876234
    PubMedGoogle Scholar
  • 2 Miller DT, Adam MP, Aradhya S. , et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86 (05) 749-764
    CrossrefPubMedGoogle Scholar
  • 3 Singh R, Gardner RJ, Crossland KM, Scheffer IE, Berkovic SF. Chromosomal abnormalities and epilepsy: a review for clinicians and gene hunters. Epilepsia 2002; 43 (02) 127-140
    CrossrefPubMedGoogle Scholar
  • 4 Galizia EC, Srikantha M, Palmer R. , et al. Array comparative genomic hybridization: results from an adult population with drug-resistant epilepsy and co-morbidities. Eur J Med Genet 2012; 55 (05) 342-348
    CrossrefPubMedGoogle Scholar
  • 5 Mefford HC. Clinical genetic testing in epilepsy. Epilepsy Curr 2015; 15 (04) 197-201
    CrossrefPubMedGoogle Scholar
  • 6 Sorge G, Sorge A. Epilepsy and chromosomal abnormalities. Ital J Pediatr 2010; 36: 36
    CrossrefPubMedGoogle Scholar
  • 7 Buiting K, Williams C, Horsthemke B. Angelman syndrome - insights into a rare neurogenetic disorder. Nat Rev Neurol 2016; 12 (10) 584-593
    CrossrefPubMedGoogle Scholar
  • 8 Kishino T, Lalande M, Wagstaff J. UBE3A/E6-AP mutations cause Angelman syndrome. Nat Genet 1997; 15 (01) 70-73
    CrossrefPubMedGoogle Scholar
  • 9 Shashidhar Pai G, Lewandowski Jr RC, Borgaonkar DS. Handbook of Chromosomal Syndromes. Hoboken, New Jersey: John Wiley & Sons Inc.; 2003
    Google Scholar
  • 10 Rubin DI, Patterson MC, Westmoreland BF, Klass DW. Angelman's syndrome: clinical and electroencephalographic findings. Electroencephalogr Clin Neurophysiol 1997; 102 (04) 299-302
    CrossrefPubMedGoogle Scholar
  • 11 Mefford HC. CNVs in epilepsy. Curr Genet Med Rep 2014; 2: 162-167
    CrossrefPubMedGoogle Scholar
  • 12 de Kovel CG, Trucks H, Helbig I. , et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 2010; 133 (Pt 1): 23-32
    CrossrefPubMedGoogle Scholar
  • 13 Helbig I, Mefford HC, Sharp AJ. , et al. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy. Nat Genet 2009; 41 (02) 160-162
    CrossrefPubMedGoogle Scholar
  • 14 Vignoli A, Scornavacca GF, Peron A, La Briola F, Canevini MP. Interstitial 6q microdeletion syndrome and epilepsy: a new patient and review of the literature. Am J Med Genet A 2013; 161A (08) 2009-2015
    PubMedGoogle Scholar
  • 15 Szafranski P, Von Allmen GK, Graham BH. , et al. 6q22.1 microdeletion and susceptibility to pediatric epilepsy. Eur J Hum Genet 2015; 23 (02) 173-179
    CrossrefPubMedGoogle Scholar
  • 16 Kumada T, Ito M, Miyajima T. , et al. Multi-institutional study on the correlation between chromosomal abnormalities and epilepsy. Brain Dev 2005; 27 (02) 127-134
    CrossrefPubMedGoogle Scholar
  • 17 Talkowski ME, Mullegama SV, Rosenfeld JA. , et al. Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. Am J Hum Genet 2011; 89 (04) 551-563
    CrossrefPubMedGoogle Scholar
  • 18 Tafakhori A, Aghamollaii V, Faghihi-Kashani S, Sarraf P, Habibi L. Epileptic syndromes: From clinic to genetic. Iran J Neurol 2015; 14 (01) 1-7
    PubMedGoogle Scholar